MARRONE BIO INNOVATIONS INC.: 10-Q filed 2016-11-14
What MARRONE BIO INNOVATIONS INC. reported in its quarterly report filed 2016-11-14 (fiscal Q3 2016): 36 published measures, 104 facts as tagged in accession 0001564590-16-029246.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2016-11-14
- Fiscal period
- fiscal Q3 2016
- Accession
- 0001564590-16-029246 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All MARRONE BIO INNOVATIONS INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 50,243,000 | USD | |
| At 2015-12-31 | 71,201,000 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 73,476,000 | USD | |
| At 2015-12-31 | 73,223,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | -23,233,000 | USD | |
| At 2015-12-31 | -2,022,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 16,013,000 | USD | |
| At 2015-12-31 | 19,838,000 | USD | |
| At 2015-09-30 | 27,837,000 | USD | |
| At 2014-12-31 | 35,324,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | -7,202,000 | USD | 92 |
| 2016-01-01 to 2016-09-30 | -23,261,000 | USD | 274 |
| 2015-07-01 to 2015-09-30 | -9,799,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -32,698,000 | USD | 273 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-09-30 | 169,000 | USD | 274 |
| 2015-01-01 to 2015-09-30 | 1,496,000 | USD | 273 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 3,634,000 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 11,352,000 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 2,475,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 7,888,000 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | -226,837,000 | USD | |
| At 2015-12-31 | -203,576,000 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 0 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 0 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 0 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 0 | USD | 273 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 17,863,000 | USD | |
| At 2015-12-31 | 18,445,000 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 698,000 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 2,025,000 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 736,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 2,921,000 | USD | 273 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | -5,275,000 | USD | 92 |
| 2016-01-01 to 2016-09-30 | -17,621,000 | USD | 274 |
| 2015-07-01 to 2015-09-30 | -8,624,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -30,251,000 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 30,639,000 | USD | |
| At 2015-12-31 | 35,912,000 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 755,000 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 2,264,000 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 687,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 2,015,000 | USD | 273 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 12,578,000 | USD | |
| At 2015-12-31 | 12,849,000 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 2,212,000 | USD | |
| At 2015-12-31 | 2,007,000 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 2,055,000 | USD | |
| At 2015-12-31 | 2,347,000 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 6,416,000 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 21,093,000 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 8,759,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 30,807,000 | USD | 273 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 8,405,000 | USD | |
| At 2015-12-31 | 9,064,000 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 1,141,000 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 3,472,000 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 135,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 556,000 | USD | 273 |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 2,493,000 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 7,880,000 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 2,340,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 7,332,000 | USD | 273 |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 3,754,000 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 13,796,000 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 5,317,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 20,615,000 | USD | 273 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 2,393,000 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 6,550,000 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 3,206,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 9,395,000 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 24,658,000 | shares | |
| At 2015-12-31 | 24,536,000 | shares |
Long-term debt
Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 57,972,000 | USD | |
| At 2015-12-31 | 57,265,000 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 181,000 | USD | |
| At 2015-12-31 | 284,000 | USD |
Other noncurrent liabilities
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 1,421,000 | USD | |
| At 2015-12-31 | 1,314,000 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 4,114,000 | USD | |
| At 2015-12-31 | 5,689,000 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 1,038,000 | USD | |
| At 2015-12-31 | 1,211,000 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | -7,202,000 | USD | 92 |
| 2016-01-01 to 2016-09-30 | -23,261,000 | USD | 274 |
| 2015-07-01 to 2015-09-30 | -9,799,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -32,698,000 | USD | 273 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | -7,202,000 | USD | 92 |
| 2016-01-01 to 2016-09-30 | -23,261,000 | USD | 274 |
| 2015-07-01 to 2015-09-30 | -9,799,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -32,698,000 | USD | 273 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-09-30 | 1,696,000 | USD | 274 |
| 2015-01-01 to 2015-09-30 | 2,616,000 | USD | 273 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | -81,000 | USD | 92 |
| 2016-01-01 to 2016-09-30 | -144,000 | USD | 274 |
| 2015-07-01 to 2015-09-30 | -1,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 40,000 | USD | 273 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | -1,927,000 | USD | 92 |
| 2016-01-01 to 2016-09-30 | -5,640,000 | USD | 274 |
| 2015-07-01 to 2015-09-30 | -1,175,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -2,447,000 | USD | 273 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-09-30 | -292,000 | USD | 274 |
| 2015-01-01 to 2015-09-30 | -398,000 | USD | 273 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-09-30 | -659,000 | USD | 274 |
| 2015-01-01 to 2015-09-30 | -2,874,000 | USD | 273 |
Inspect the source
- Entity
- MARRONE BIO INNOVATIONS INC. / CIK 0001441693
- Captured
- SEC response SHA-256
a3787009c5cf9f0620a14ee2be8261876f11bbb6e3e32c9de2e3e341c6f35189
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001441693.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))